Literature DB >> 2476115

Activation of human protein C by blood coagulation factor Xa in the presence of anionic phospholipids. Enhancement by sulphated polysaccharides.

J M Freyssinet1, M L Wiesel, L Grunebaum, J M Pereillo, J Gauchy, S Schuhler, G Freund, J P Cazenave.   

Abstract

The activation of protein C by thrombin is thought to occur at the endothelial cell surface in the presence of an essential membrane glycoprotein cofactor, thrombomodulin. In the present study it is demonstrated that, in the presence of hirudin, the most potent known inhibitor of thrombin, human protein C can be activated by human factor Xa (20 nM), but by a thrombomodulin-independent mechanism requiring only the presence of Ca2+ and phospholipid vesicles bearing a high proportion of negative charges (30-75% phosphatidylserine, depending on the conditions). At an optimal concentration of phosphatidylserine/phosphatidylcholine (1:1, w/w) of 75 microM, the apparent Km was 1 microM with a kcat. of 1 min-1. At 25 microM-phospholipid the Km was unchanged and the kcat. was 0.67 min-1. At either lipid concentration, increasing the density of negative charges by the adjunction of sulphated polysaccharides, like pentosan polysulphate or standard heparin at optimal concentrations of 2-5 micrograms/ml and 5-10 micrograms/ml respectively, resulted in a 4-fold increase of the kcat. without affecting the Km. Sulphated polysaccharides alone were poor promoters of protein C activation by factor Xa. In any case the presence of Ca2+ was essential, the dependence being sigmoidal with Hill coefficients ranging from 1.4 to 2.0. No significant activation of 4-carboxyglutamic acid-domainless protein C, a chymotrypic derivative lacking the phospholipid-binding domain, could be detected in the presence of phospholipids and Ca2+, with or without pentosan polysulphate. In a large molar excess, other phospholipid-binding entities like prothrombin fragments F1 or F1+2 could inhibit protein C activation by factor Xa, but pentosan polysulphate exerted a clear protective effect. Factor Xa irreversibly inhibited at its active centre, but not di-isopropyl phosphoro-thrombin, behaved as an inhibitor but in a more complex manner than simple Michaelis-Menten kinetics. Among several derivatives of pentosan polysulphate or of heparin which were tested, those having the higher degree of sulphation and/or molecular mass were the most efficient in enhancing the rate of activation of protein C by factor Xa in the presence of phospholipids. These results suggest that human factor Xa, at physiological concentrations, could activate human protein C in the presence of anionic phospholipids and that this activation could be potentiated by therapeutic concentrations of sulphated polysaccharides.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2476115      PMCID: PMC1138831          DOI: 10.1042/bj2610341

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  The activation of bovine coagulation factor X.

Authors:  J Jesty; Y Nemerson
Journal:  Methods Enzymol       Date:  1976       Impact factor: 1.600

2.  Human thrombomodulin: complete cDNA sequence and chromosome localization of the gene.

Authors:  D Z Wen; W A Dittman; R D Ye; L L Deaven; P W Majerus; J E Sadler
Journal:  Biochemistry       Date:  1987-07-14       Impact factor: 3.162

3.  Membrane asymmetry and blood coagulation.

Authors:  R F Zwaal; P Comfurius; L L van Deenen
Journal:  Nature       Date:  1977-07-28       Impact factor: 49.962

4.  The inhibition by heparin of the intrinsic pathway activation of factor X in the absence of antithrombin-III.

Authors:  F Ofosu; M A Blajchman; J Hirsh
Journal:  Thromb Res       Date:  1980-11-15       Impact factor: 3.944

Review 5.  Factor V.

Authors:  M E Nesheim; J A Katzmann; P B Tracy; K G Mann
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

6.  Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets.

Authors:  E M Bevers; P Comfurius; J L van Rijn; H C Hemker; R F Zwaal
Journal:  Eur J Biochem       Date:  1982-02

7.  Interactions between heparin and factor Xa. Inhibition of prothrombin activation.

Authors:  F J Walker; C T Esmon
Journal:  Biochim Biophys Acta       Date:  1979-07-04

8.  The conversion of prothrombin to thrombin. I. Characterization of the reaction products formed during the activation of bovine prothrombin.

Authors:  W G Owen; C T Esmon; C M Jackson
Journal:  J Biol Chem       Date:  1974-01-25       Impact factor: 5.157

9.  Activation of protein C in vivo.

Authors:  P C Comp; R M Jacocks; G L Ferrell; C T Esmon
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

10.  Selective distribution of the heparin in mammals: conspicuous presence of heparin in lymphoid tissues.

Authors:  H B Nader; H K Takahashi; A H Straus; C P Dietrich
Journal:  Biochim Biophys Acta       Date:  1980-01-03
View more
  3 in total

1.  Thrombin interaction with a recombinant N-terminal extracellular domain of the thrombin receptor in an acellular system.

Authors:  M C Bouton; M Jandrot-Perrus; S Moog; J P Cazenave; M C Guillin; F Lanza
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

2.  Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells.

Authors:  C Ravanat; G Archipoff; A Beretz; G Freund; J P Cazenave; J M Freyssinet
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

3.  Oyxsterols induce membrane procoagulant activity in monocytic THP-1 cells.

Authors:  K Aupeix; F Toti; N Satta; P Bischoff; J M Freyssinet
Journal:  Biochem J       Date:  1996-03-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.